Eva Weisz
Impact in
- Immunology top 10%
- Immune Cell Function and Interaction
- T-cell and B-cell Immunology
- Oncology top 10%
- Cytokine Signaling Pathways and Interactions
Papers in
- Oncology 9
- Cytokine Signaling Pathways and Interactions 6
-
- Immune Cell Function and Interaction 6
- Co-authors
- Veronika Sexl (9 shared papers)Michael Freissmuth (7 shared papers)Dagmar Stoiber (6 shared papers)Boris Kovačic (4 shared papers)René G. Ott (3 shared papers)Richard Moriggl (3 shared papers)David E. Levy (1 shared paper)Hartmut Beug (1 shared paper)
- Journals
- Blood (3 papers)Journal of Clinical Investigation (2 papers)Journal of Pharmacology and Experimental Therapeutics (1 paper)Journal of Biological Chemistry (1 paper)Cancer Research (1 paper)
- Partner nations
- AustriaUnited StatesFrance
In The Last Decade
Eva Weisz
11 papers receiving 480 citations
Peers
Comparison fields: 5 of 57
- Immunology 201
- Oncology 221
- Genetics 67
- Hematology 49
- Pathology and Forensic Medicine 68
Countries citing papers authored by Eva Weisz
This map shows the geographic impact of Eva Weisz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eva Weisz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eva Weisz more than expected).
Fields of papers citing papers by Eva Weisz
This network shows the impact of papers produced by Eva Weisz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eva Weisz. The network helps show where Eva Weisz may publish in the future.
Co-authors
The 25 scholars most cited alongside Eva Weisz, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2006 | 128 | |
| 2 | 2003 | 68 | |
| 3 | 2004 | 52 | |
| 4 | 2004 | 52 | |
| 5 | 2001 | 44 | |
| 6 | 2008 | 38 | |
| 7 | 2008 | 28 | |
| 8 | 2003 | 26 | |
| 9 | 2006 | 26 | |
| 10 | 2007 | 19 | |
| 11 | 1990 | 6 |
About Eva Weisz
Eva Weisz is a scholar working on Oncology, Immunology, Molecular Biology, Cancer Research and Genetics, having authored 11 papers that have together received 487 indexed citations. Recurring topics across this work include Cytokine Signaling Pathways and Interactions (6 papers), Immune Cell Function and Interaction (6 papers), NF-κB Signaling Pathways (3 papers), Chronic Lymphocytic Leukemia Research (2 papers), Ubiquitin and proteasome pathways (1 paper), Acute Lymphoblastic Leukemia research (1 paper), Ion channel regulation and function (1 paper) and Glycosylation and Glycoproteins Research (1 paper). The work is most often cited by research in Immunology (201 citations), Oncology (221 citations), Genetics (67 citations), Hematology (49 citations) and Pathology and Forensic Medicine (68 citations). Eva Weisz has collaborated with scholars based in Austria, United States and France. Frequent co-authors include Veronika Sexl, Michael Freissmuth, Dagmar Stoiber, Boris Kovačic, René G. Ott, Richard Moriggl, David E. Levy, Hartmut Beug, Michaela Artwohl and Christian Schuster. Their work appears in journals such as Blood, Journal of Clinical Investigation, Journal of Pharmacology and Experimental Therapeutics, Journal of Biological Chemistry and Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.